Are natriuretic peptides useful biomarkers in dialysis patients?

Peritoneal Dialysis International

Volumn 27, Issue 6, 2007, Pages 636-640

  van den Kerkhof, Jos J ^a   van der Sande, Frank M ^a   Leunissen, Karel ^a   Kooman, Jeroen P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIAGNOSTIC VALUE; DIALYSIS; DRY WEIGHT; FLUID BALANCE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FAILURE; HEMODIALYSIS PATIENT; HUMAN; HYPERVOLEMIA; NORMAL VALUE; NOTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; ULTRAFILTRATION; BLOOD; BODY FLUID; METABOLIC DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

BIOLOGICAL MARKERS; BODY FLUIDS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; NATRIURETIC PEPTIDES; PROGNOSIS; RENAL DIALYSIS; WATER-ELECTROLYTE IMBALANCE;

EID: 41049096583     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700606     Document Type: Note

References (38)

1. Akashi YJ, Springer J, Lainscak M, Anker SD. Review: Atrial natriuretic peptide and related peptides. Clin Chem Lab Med 2007 Jul 30; [Epub ahead of print].
2. Rascher W, Tulassay T, Lang RE. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet 1985; 2:303-5.
3. Yamamoto Y, Higa T, Kitamura K, Tanaka K, Kangawa K, Matsuo H. Plasma concentration of atrial natriuretic polypeptide in chronic hemodialysis patients. Regul Pept Suppl 1985; 4:110-12.
4. Jaeger JQ, Mehta RL. Assessment of dry weight in dialysis patients: an overview. J Am Soc Nephrol 1999; 10:392-403.
5. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, de Vries PMJM, Leunissen KML. Assessment of postdialysis dry weight. J Am Soc Nephrol 1993; 4:98-104.
6. Suresh M, Farrington K. Natriuretic peptides and the dialysis patient. Semin Dial 2005; 18:409-19.
7. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-7.
8. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92: 843-9.
9. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6:257-60.
10. de Lemos JA, McGuire DK, Drzner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.
11. Rosner MH. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? Kidney Int 2007; 71:481-3.
12. Kroll MH, Srisawasdi P. The clearance of BNP modeled using the NT-proBNP-BNP relationship. Biosystems 2007; 88:147-55.
13. Schou M, Dalsgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 2005; 99:1676-80.
14. McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev 2003; 8:355-8.
15. deFilippi CR, Seliger SL, Maynard S, Christenson RH. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 2007; 53:1511-19.
16. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005; 46:610-20.
17. Mark PB, Stewart GA, Gansevoort RT, Petrie CJ, McDonagh TA, Dargie HJ, et al. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 2006; 21:402-10.
18. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, et al. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 2007; 18:321-30.
19. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003; 41:1257-66.
20. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004; 50:1071-4.
21. van de Pol AC, Frenken LA, Moret K, Baumgarten R, van der Sande FM, Beerenhout CM, et al. An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. Hemodial Int 2007; 11:51-61.
22. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 2007; 71:548-54.
23. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005; 46:118-23.
24. Chenevier-Gobeaux C, Claessens YE, Voyer S, Desmoulins D, Ekindjian OG. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the emergency department: comparison with brain natriuretic peptide (BNP). Clin Chim Acta 2005; 361:167-75.
25. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59:1559-66.
26. deFilippi CR, Fink JC, Nass CM, Chen H, Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 2005; 46:35-44.
27. van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM, et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 2006; 48:1621-7.
28. Bavbek N, Akay H, Altay M, Uz E, Turgut F, Uyar ME, et al. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007; 27:663-8.
29. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-15.
30. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-44.
31. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004; 50:2279-85.
32. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007; 37:350-6.
33. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95:c60-6.
34. Clerico A, Caprioli R, Del Ry S, Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 2001; 24:24-30.
35. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, et al. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 2007; 153:244.e1-5.
36. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid state, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
37. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET. Association between serum N-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26:360-5.
38. Boudville NC, Cordy P, Millman K, Fairbairn L, Sharma A, Lindsay R, et al. Blood pressure, volume, and sodium control in an automated peritoneal dialysis population. Perit Dial Int 2007; 27:537-43.